gptkbp:instanceOf
|
vaccine
|
gptkbp:administeredBy
|
gptkb:Hib_vaccine
HepB vaccine
IPV vaccine
PCV vaccine
|
gptkbp:alternativeTo
|
DTwP vaccine
|
gptkbp:approvedBy
|
gptkb:FDA
|
gptkbp:ATCCode
|
J07AJ52
|
gptkbp:boosterInterval
|
every 10 years (as Tdap for adults)
|
gptkbp:boosterRecommended
|
yes
|
gptkbp:broadcastOn
|
6 months
4-6 years
2 months
15-18 months
4 months
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
many other countries
|
gptkbp:developedBy
|
1990s
|
gptkbp:hasComponent
|
diphtheria toxoid
tetanus toxoid
acellular pertussis antigens
|
https://www.w3.org/2000/01/rdf-schema#label
|
DTaP vaccine
|
gptkbp:notRecommendedFor
|
adults
pregnant women
|
gptkbp:protectedBy
|
diphtheria
tetanus
pertussis
|
gptkbp:recommendation
|
children
|
gptkbp:replacedBy
|
Tdap vaccine (for older children and adults)
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
gptkbp:sideEffect
|
fever
swelling at injection site
redness at injection site
mild fussiness
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
gptkbp:bfsParent
|
gptkb:Whooping_Cough
|
gptkbp:bfsLayer
|
5
|